Secukinumab demonstrates high efficacy and a favorable safety profile over 52 weeks in Chinese patients with moderate to severe plaque psoriasis
- Resource Type
- Journal
- Authors
- Cai, Lin; Zhang, Jian-Zhong; Yao, Xu; Gu, Jun; Liu, Quan-Zhong; Zheng, Min; Zhang, Shi-Fa; Xu, Jin-Hua; Li, Cheng-Xin; Cheng, Hao; Guo, Qing; Pan, Wei-Li; Li, Shen-Qiu; Li, Ruo-Yu; Guo, Zai-Pei; Song, Zhi-Qi; Li, Shan-Shan; Dong, Xiu-Qin; Wang, Linda; Fu, Rong; Regnault, Pascaline; Charef, Pascal; Mazur, Rafal; Patekar, Manmath
- Source
- CHINESE MEDICAL JOURNAL; NOV 20 2020, 133 22, p2665-p2673, 9p.
- Subject
- Language
- English
- ISSN
- 25425641